THE AGREEMENT ON COOPERATION IN FIGHT AGAINST THE ADDRESS OF COUNTERFEITED MEDICINES

of November 14, 2008

The governments of the State Parties of the Commonwealth of Independent States which further are referred to as with the Parties

attaching special significance to providing the population with effective, safe and high-quality medicines in necessary amount and assortment,

understanding that the address of counterfeited medicines poses serious health hazard and to welfare of the population of the states of the Parties,

considering need of acceptance of urgent measures for the prevention, identification and suppression of the address, including export and import, counterfeited medicines for the states of the Parties,

recognizing feasibility of enhancement of the regulatory legal acts regulating drug circulation in the states of the Parties

based on recommendations of the World Health Organization about fight against the address of counterfeited medicines,

being guided by the commonly accepted rules of international law, international treaties, the legislation of the states of the Parties, agreed as follows:

Article 1

Subject of this agreement is the cooperation of the Parties in fight against the address of counterfeited medicines.

Article 2

The cooperation of the Parties concerning fight against the address of counterfeited medicines, including against their export and import, within this agreement is performed in the following main directions:

holding the approved actions for fight against the address of counterfeited medicines, including when carrying out controlled deliveries;

harmonization of the regulatory legal acts regulating drug circulation according to international standards, including with recommendations of the World Health Organization;

exchange of information about the applied methods of concealment and masking of counterfeited medicines during the transporting and sale, and also about methods of their identification;

information exchange, exchange of legislative and other regulatory legal acts of the states of the Parties;

development of methodical recommendations about quality control of medicines and to identification of counterfeited medicines;

Disclaimer! This text was translated by AI translator and is not a valid juridical document. No warranty. No claim. More info